InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: None

Saturday, 08/29/2015 4:23:49 PM

Saturday, August 29, 2015 4:23:49 PM

Post# of 461248
The good doctor designed the trials to be efficient as possible with the FDA blessings. If phase IIa results are as good or better than the prelim.
Then 2-73 becomes a viable platform for other CNS drugs (Go directly to Phase II as they will do with Parkinson's). I also believe the going to market time will be much quicker than the norm. The political environment will insure this.
The value of this company will be more in lines with George's estimates.

My opinion....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News